⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5890519 | 0.92 | — | — | |
| Trimethylammonium SCHEMBL6115143 | 0.90 | THRB (0.31) | — | |
| SCHEMBL6055923 | 0.89 | PTPN1 (0.36) | — | |
| SCHEMBL66179 | 0.81 | — | — | |
| SCHEMBL19691770 | 0.81 | — | — | |
| SCHEMBL758285 | 0.81 | THRB (0.44) | — | |
| SCHEMBL6358420 | 0.80 | PTPN1 (0.37) | — | |
| SCHEMBL735059 | 0.80 | — | — | |
| SCHEMBL18280923 | 0.79 | — | — | |
| SCHEMBL28393486 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11052153-B2 | Highly branched alpha-D-glucans | PURDUE RESEARCH FOUNDATION (US) | 2021-07-06 | — | — | US | claimed |
| CN-105582438-A | Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition | SUN WEI | 2016-05-18 | — | — | CN | claimed |
| CN-105497516-A | Drug for radioactive leukopenia and preparation method thereof | SUN WEI | 2016-04-20 | — | — | CN | claimed |
| CN-105057659-A | Molding method of copper base alloy powder ultrathin part | MECHANICAL DESIGN INST OF SHAANXI PROVINCE | 2015-11-18 | — | — | CN | claimed |
| US-20140272021-A1 | ETHYL ALCOHOL EMITTING PACKAGE FOR BAKED GOODS | MULTISORB TECHNOLOGIES, INC. (US) | 2014-09-18 | — | — | US | claimed |
| CN-102935232-A | Production and application methods of magnesium-stearate-containing medicinal premix auxiliary material used in direct tableting or capsule filling | SUN PEIXIONG | 2013-02-20 | — | — | CN | claimed |
| CN-101792542-A | Method for preparing water soluble mixed ether by using corn bran and wheat bran | SHENZHEN PROFESSIONAL ADVANCED BIOCHEMISTRY TECHNOLOGY CO LTD | 2010-08-04 | — | — | CN | claimed |
| US-20070015792-A1 | N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives | MSD K.K. (JP) | 2007-01-18 | — | — | US | claimed |
| US-20230346802-A1 | UNIT DOSE PHARMACEUTICAL OF A DRY POWDER OF ONE OR MORE GLUCOCORTICOID OR MINERALOCORTICOID FLUDROCORTISONE ACETATE AND/OR TRIAMCINOLONE ACETONIDE COMPRISED IN A SYRINGE | EYE CO PTY LTD (AU) | 2023-11-02 | — | — | US | disclosed |
| US-11735737-B2 | Binder for electricity storage devices improving dispersibility of conductive assistant | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2023-08-22 | — | — | US | disclosed |
| US-11701368-B2 | Unit dose pharmaceutical of a dry powder of one or more glucocorticoid or mineralocorticoid fludrocortisone acetate and/or triamcinolone acetonide comprised in a syringe | EYE CO PTY LTD (AU) | 2023-07-18 | — | — | US | disclosed |
| EP-4020081-B1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM, PATTERNING PROCESS, AND SILICON COMPOUND | SHINETSU CHEMICAL CO (JP) | 2023-05-17 | — | — | EP | disclosed |
| US-20220390458-A1 | FLUORESCENT PROBE AND APPLICATIONS THEREOF | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2022-12-08 | — | — | US | disclosed |
| EP-4023686-A1 | BINDER FOR ELECTRICITY STORAGE DEVICES IMPROVING DISPERSIBILITY OF CONDUCTIVE ASSISTANT | FUJIFILM Wako Pure Chemical Corporation (JP) | 2022-07-06 | — | — | EP | disclosed |
| EP-0533727-A1 | ADSORBENT MATERIAL FOR SELECTIVE REMOVAL OF LDL OR/AND vLDL. | BRAUN MELSUNGEN AG (DE) | 1993-03-31 | — | — | EP | disclosed |
| EP-0530681-A1 | Silver halide color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1993-03-10 | — | — | EP | disclosed |
| WO-1991019565-A1 | ADSORBENT MATERIAL FOR SELECTIVE REMOVAL OF LDL OR/AND vLDL | B. BRAUN MELSUNGEN AG (DE) | 1991-12-26 | — | — | WO | disclosed |
| EP-0448726-A1 | 2-SUBSTITUTED 2-CYCLOPENTENONE AND CARCINOSTATIC AGENT AND OSTEOGENESIS PROMOTER CONTAINING THE SAME AS ACTIVE INGREDIENT | TEIJIN LIMITED (JP) | 1991-10-02 | — | — | EP | disclosed |
| EP-0261213-A1 | FORMULATION FOR PREPARING SUSTAINED RELEASE DRUGS FOR ORAL ADMINISTRATION. | EURAND SPA (IT) | 1988-03-30 | — | — | EP | disclosed |
| WO-1987005212-A1 | FORMULATION FOR PREPARING SUSTAINED RELEASE DRUGS FOR ORAL ADMINISTRATION | EURAND ITALIA S.P.A. (IT) | 1987-09-11 | — | — | WO | disclosed |